Business
Hikma update on global Injectables business
Hikma update on global Injectables business.
About this update from Hikma Pharmaceuticals Plc
[{"type":"text","content":"\n \nRNS Number : 5149C Hikma Pharmaceuticals Plc 17 April 2013 \n \n\n \n \n \nPRESS RELEASE \n \n \nHikma provides update on its global Injectables business\nLondon, 17 April 2013 - Further to its announcement of 1 March 2013 that it was undertaking a review of the strategic options for its global Injectables business, Hikma Pharmaceuticals PLC (\"Hikma\") (LSE:HIK) (NASDAQ Dubai: HIK), the fast growing pharmaceutical group, today announces that it has concluded this strategic review and has determined that this business should remain part of the Hikma Group.\n \nHikma's Board has noted the significant amount of interest shown in its Injectables business by third parties, demonstrating both the attractiveness of the global injectables market and the strength of the business.\n &...